--- title: A clinical trial for the treatment of severe COVID-19 disease progression is funded by the BMBF | HiGHmed description: April 23, 2021 A clinical trial for the treatment of severe COVID-19 disease progression is funded by the BMBF “Unfortunately we have to expect that people image: https://www.highmed.org/hubfs/CD/Bilder/News/CATCOVID_MitQuelle_1100x620-1.jpg --- [Skip to content](https://www.highmed.org/news/catcovid#main-content) [info@highmed-lehre.de](mailto:geschaeftsstelle@highmed.org) [![LOGO_NEU_HIGHMED](https://www.highmed.org/hs-fs/hubfs/LOGO_NEU_HIGHMED.png?width=250&height=141&name=LOGO_NEU_HIGHMED.png)](https://www.highmed.org/en/home?hsLang=en) - About us - [Our History](https://www.highmed.org/en/highmed-project-about-us-our-history) - [Our Vision](https://www.highmed.org/en/about-us-our-visions) - [Our MeDICs](https://www.highmed.org/en/highmed-consortium/medics) - [Our Team](https://www.highmed.org/en/our-team) - Our Governance Bodies - [Consortium](https://www.highmed.org/en/highmed-governance-bodies) - [Mgmt. & Superv. Board of Association](https://www.highmed.org/en/management-supervisory-board) - [Rules of Procedures of Association](https://www.highmed.org/en/statutes-and-rules-of-procedure) - Activities - openEHR - [Introduction openEHR](https://www.highmed.org/en/en/introduction-openehr) - [openEHR worldwide](https://www.highmed.org/en/worldwide-openehr) - [GERMAN openEHR Modeling Group](https://www.highmed.org/en/german-openehr-modelinggroup) - Use Cases - 2023-2026 - [PCOR-MII](https://www.highmed.org/en/pcor-mii) - [EyeMatics](https://www.highmed.org/en/eyematics) - [ACRIBiS](https://www.highmed.org/en/acribis) - [RISK PRINCIPE](https://www.highmed.org/en/use-case-risk-principe) - [Junior Research Groups | Overview](https://www.highmed.org/en/junior-research-groups-overview) - Insights - [Publications](https://www.highmed.org/en/publications) - [HIGHmed Events](https://www.highmed.org/en/our-highmed-events) - [Partners](https://www.highmed.org/en/highmed-partners-members) - Contact - [Project Management Office](https://www.highmed.org/en/contact-us-highmed) - [Site/MeDIC Lead](https://www.highmed.org/en/highmed-contacts-representatives) - [English](https://www.highmed.org/news/catcovid) - [Deutsch](https://www.highmed.org/de/news/catcovid) English # A clinical trial for the treatment of severe COVID-19 disease progression is funded by the BMBF [Press & Public Relations](https://www.highmed.org/news/author/press-public-relations) 23 Apr, 21 15:45 PM No quod sanctus instructior ius, et intellegam interesset duo. Vix cu nibh gubergren dissentias. His velit veniam habemus ne. No doctus neglegentur vituperatoribus est, qui ad ipsum oratio. Ei duo dicant facilisi, qui at harum democritum consetetur. ![](https://www.highmed.org/hubfs/CD/Bilder/News/CATCOVID_MitQuelle_1100x620-1.jpg) “Unfortunately we have to expect that people will continue to fall ill with COVID-19 in the foreseeable future. We therefore urgently need to increase our arsenal of effective drugs,” said Federal Research Minister Anja Karliczek. Therefore safe and effective drugs are needed to treat those who become sick. For that reason the German Federal Ministry of Education and Research (BMBF) is funding research into drugs against COVID-19. With this aim in mind the two HiGHmed partners Charité and the University Hospital Würzburg (UKW) as well as the associated HiGHmed-partner Unfallkrankenhaus Berlin (UKB) have joined forces with the Berlin Institute of Health (BIH), Bayer and the University Hospital Leipzig (UKL) for a multi-site COVID-19 study. In close cooperation with HiGHmed e.V. the joint project application was submitted to the BMBF and is now one of the eight projects to be funded. For the official press release of the BIH click [**here**](https://www.bihealth.org/en/notices/bih-launches-clinical-trial-of-the-treatment-of-severe-covid-19-disease-progression).   ## Leave a Comment ## Related Posts ### [22 Dec, 21 11:27 AM Multicenter CATCOVID trial enrolls first patient](https://www.highmed.org/news/multicenter-catcovid-trial-enrolls-first-patient?hsLang=en) ### [23 Oct, 25 14:09 PM Training Project on Broad Consent at UKHD](https://www.highmed.org/news/training-project-on-broad-consent-at-ukhd?hsLang=en) ### [4 May, 26 10:00 AM 2nd PCOR-MII Consortium Meeting in Berlin!](https://www.highmed.org/news/2nd-pcor-mii-consortium-meeting-in-berlin?hsLang=en) ![image006](https://www.highmed.org/hs-fs/hubfs/image006.png?width=2203&name=image006.png)   #### Contact Us [info@highmed-lehre.de](mailto:-info@highmed-lehre.de)  #### Follow Us © 2026 HiGHmed // Medical Informatics - [Privacy Policy](https://www.highmed.org/en/privacy-policy) - [Imprint](https://www.highmed.org/en/imprint) ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "dateModified" : "2024-10-01", "datePublished" : "2024-10-01", "headline" : "A clinical trial for the treatment of severe COVID-19 disease progression is funded by the BMBF", "image" : [ "https://f.hubspotusercontent30.net/hubfs/19954885/CD/Bilder/News/CATCOVID_MitQuelle_1100x620-1.jpg" ], "mainEntityOfPage" : { "@id" : "https://www.highmed.org/news/catcovid", "@type" : "WebPage" } } ```